Nataly Tarasenko

Title: Nataly Tarasenko: Innovator in Drug Conjugates

Introduction

Nataly Tarasenko is a prominent inventor based in Petah-Tikva, Israel. She has made significant contributions to the field of drug development, particularly in the area of cancer treatment and cosmetic applications. Her innovative work has led to the creation of novel drug conjugates that hold promise for various therapeutic uses.

Latest Patents

Nataly Tarasenko holds a patent for "5-aminolevulinic acid derivatives, methods for their preparation and uses thereof." This invention provides drug conjugates comprising 5-aminolevulinic acid (ALA), an aldehyde, and a carboxylic acid that may function as a histone deacetylase inhibitor (HDACI). These conjugates can serve as co-drugs that release multiple active species in vivo. The novel drug conjugates are intended for the treatment or prevention of cancer in both PDT-dependent and PDT-independent treatments, as well as for cosmetic uses. Additionally, the invention outlines new applications for both novel and known compounds.

Career Highlights

Throughout her career, Nataly has worked with esteemed institutions such as Bar-Ilan University and Ramot at Tel Aviv University Ltd. Her research has focused on developing innovative solutions that address critical health challenges.

Collaborations

Nataly has collaborated with notable colleagues, including Ada Rephaeli and Zvi Malik. These partnerships have contributed to her success in advancing her research and patent applications.

Conclusion

Nataly Tarasenko's work exemplifies the impact of innovation in drug development. Her contributions to the field are paving the way for new treatments and applications that could benefit many.